the lrc-cppt study , involving cholestyramine , has provided conclusive evidence concerning the benefits of lowering cholesterol : significant reductions were observed in all cardiovascular end points measured , including the development of angina and positive exercise stress tests , referral for bypass surgery , and the hard primary study end point heart attack and heart attack death .
C0007226
cardiovascular
C0027051
heart attack